drugset / Trial / NCT00687167
Fed Bioavailability Study of Zonisamide Capsules
RandomizedCrossoverSingle-blindBasic science
Summary
The purpose of this study is to evaluate the relative bioavailability (rate and extent of absorption) of a test formulation of zonisamide capsules compared to the reference formulation, Zonegran® (zonisamide)capsules, after a single oral dose administered under non-fasting conditions.
Timeline
- Start
- 2005-01
- Primary completion
- 2005-03
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.